GSK recalls 600,000 Ventolin Inhalers from US

GSK recalls 600,000 Ventolin Inhalers from US

Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol  (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.

The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.

The inhalers, according to reports,  have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.

“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”

The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.

About author

You might also like

NEWS 1Comments

New Nutrition Health Survey out

• Reveals low-skilled birth attendance, low administration of Vitamin A, others>  The report of 2018 National Nutrition and Health Survey (NNHS) released by Nigerian government on Monday November 19, has

NEWS 0 Comments

Donor funds enough to place 3.2 Nigerian HIV patients on treatment – NACA DG

Donor funds from the Global Fund, US President’s Emergency Plan For AIDS Relief (PEPFAR), among others, are enough to place no fewer than 3.2 million Nigerians  currently living with HIV

HPV vaccination kicks off September 25 

As NPHCDA battles cervical cancer To prevent the spread of cervical cancer, the federal government has said it would introduce Human Papilloma Virus, HPV, on September 25, 2023 and to

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply